Seeing Is Believing
Currently, out of the existing stock ratings of Derek Archila - 119 which are a Buy (68%), 53 which are a Hold (30.29%), 3 which are a Sell (1.71%)
Analyst Derek Archila works at WELLS FARGO and is covering the Healthcare sector with 361 price targets and ratings displayed on 35 stocks. Previously, Derek Archila worked at STIFEL, OPPENHEIMER.
Derek Archila's average stock forecast success ratio is 47.64% with an average time for price targets to be met of 124.91 days.
Most recent stock forecast was given on IMVT, Immunovant at 27-Sep-2023.
Analyst best performing recommendations are on ARNA (ARENA PHARMACEUTICALS).
The best stock recommendation documented was for ARNA (ARENA PHARMACEUTICALS) at 12/10/2021. The price target of $71 was fulfilled within 3 days with a profit of $21.06 (42.17%) receiving and performance score of 140.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
18
3 years 27 days ago
6/6 (100%)
$3.64 (16.58%)
157
Hold
14
$-20.49 (-59.41%)
14
3 years 27 days ago
7/8 (87.5%)
$2.22 (15.79%)
134
Buy
24
$-10.49 (-30.41%)
24
3 years 27 days ago
10/22 (45.45%)
$22.37 (109.27%)
397
Buy
34
$-0.49 (-1.42%)
60
3 years 28 days ago
0/23 (0%)
$34.4 (149.79%)
Buy
34
$-0.49 (-1.42%)
66
3 years 28 days ago
0/13 (0%)
$38.1 (173.06%)
Which stock is Derek Archila is most bullish on?
Which stock is Derek Archila is most reserved on?
What Year was the first public recommendation made by Derek Archila?